In this radio interview, pharmacist Dr. Megan Kilkeary shared insights about her extensive experience in compounding, particularly with low-dose naltrexone (LDN). With nearly 20 years of experience in pharmacy, Dr. Kilary emphasized the importance of high-quality compounding, noting that her pharmacy offers LDN in various forms, including tablets, liquids, topical creams, and sublingual options. The most popular dosage is 4.5 mg tablets, which are designed for easy titration. She also highlighted the pharmacy's commitment to potency testing, ensuring that patients receive consistent dosages.

For patients interested in microdosing, especially those looking to taper off opioid therapy or manage addiction issues, a liquid form of LDN is available. Dr. Kilkeary mentioned the topical application of LDN, which shows promise for skin conditions like psoriasis and eczema but recommended oral forms for systemic effects. The conversation also touched upon the benefits of sublingual administration, which bypasses first-pass metabolism in the liver, potentially increasing medication availability. Overall, Dr. Kilkeary's focus is on providing patients with effective, high-quality compounded LDN to address various health conditions.

Strive Pharmacy are flipping the script with personal medicine the human element is their crux and catalyst driving all that they do whether interacting with patients providers or practices they are more than a compounding pharmacy they're on a mission to positively disrupt health care as we know it.